News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Bristol-Myers Squibb Canada Profit Triples on Sale of Device Unit
October 23, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK (Reuters) - Bristol-Myers Squibb Co on Thursday said third-quarter earnings tripled from the sale of its ConvaTec wound-healing unit and higher drug sales, but the company took another big charge for soured investments.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Layoffs
Rallybio Downsizes by 40% After Dropping Lead Asset
May 9, 2025
·
2 min read
·
Tristan Manalac
Earnings
Novavax Sales Jump 600% YoY as COVID-19 Vaccine Still in Limbo at FDA
May 8, 2025
·
3 min read
·
Heather McKenzie
Cell therapy
Vor Bio Looks for Exit in Challenging Funding Environment; Lays Off 95% of Staff
May 8, 2025
·
1 min read
·
Dan Samorodnitsky
Job Trends
Job Market Woes: More Funding, Stability Needed for Turnaround
May 8, 2025
·
5 min read
·
Angela Gabriel
